Silo Pharma (SILO) Net Shares Issued and Repurchased (2024 - 2025)
Silo Pharma's (SILO) quarterly Net Shares Issued and Repurchased came in at $500000.0 in Q4 2025, up 8233.33% year-over-year from $6000.0 in Q4 2024, and up 8233.33% quarter-over-quarter from $6000.0 in Q4 2024.
Powered by 
Analysis
Silo Pharma (SILO) Net Shares Issued and Repurchased (2024 - 2025) Analysis & Trends
Silo Pharma has disclosed Net Shares Issued and Repurchased across 2 years of filings, most recently posting $500000.0 for Q4 2025.
- In Q4 2025, Net Shares Issued and Repurchased rose 8233.33% year-over-year to $500000.0; the TTM figure through Dec 2025 stood at $500000.0 (up 8233.33% YoY), while the FY2025 annual figure was $500000.0, up 8233.33% from the prior year.
- Net Shares Issued and Repurchased came in at $500000.0 for Q4 2025 at Silo Pharma, up from $6000.0 in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $500000.0 in Q4 2025 to a low of $6000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 209.94 Bn | 195.95 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.74 Bn | 176.57 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.05 Bn | 124.20 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.43 Bn | 74.44 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.23 Bn | 56.04 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.42 Bn | 48.28 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.77 Bn | 30.47 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.62 Bn | 30.33 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Silo Pharma | 2.49 Mn | 2.49 Mn | - | - |